Publications by authors named "H El Kabiri"
Background: Colorectal cancer (CRC), now the second most prevalent malignant tumor worldwide, is more prevalent in young adults. In recent decades, there has been progress in creating anti-colorectal cancer medications, including cytotoxic compounds.
Objectives: Novel anticancer drugs are needed to surmount existing obstacles.
The advent of iPSCs has brought about a significant transformation in stem cell research, opening up promising avenues for advancing cancer treatment. The formation of cancer is a multifaceted process influenced by genetic, epigenetic, and environmental factors. iPSCs offer a distinctive platform for investigating the origin of cancer, paving the way for novel approaches to cancer treatment, drug testing, and tailored medical interventions.
View Article and Find Full Text PDFCorrigendum to "Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer" [Int. Immunopharmacol. 115 (2023) 109622].
Int Immunopharmacol
November 2023
Article Synopsis
- The study focused on developing and characterizing a new formulation of undecylenoyl phenylalanine (Sepiwhite) loaded into nanostructured lipid carriers (NLCs) aimed at reducing melanin production in the skin.
- An optimized SEPI-NLC formulation showed promising results with a small particle size of 180.1 nm, high entrapment efficiency of 90.81%, and a stable shelf life of 9 months at room temperature.
- The findings indicated that SEPI-NLCs had superior skin permeation and anti-tyrosinase activity compared to traditional formulations, indicating their potential effectiveness for treating hyperpigmentation.
Nanoparticles (NPs) may help treat multidrug-resistant Staphylococcus aureus (MDR). This study prepared and evaluated chitosan/alginate-encapsulated Echinacea angustifolia extract against MDR strains. Evaluating synthesized NPs with SEM, DLS, and FT-IR.
View Article and Find Full Text PDF